Research Reports on Top Stocks: Research In Motion, Microsoft, Ariad, Nokia, VeriFone, and Williams Companies

VANCOUVER, British Columbia, Dec. 17, 2012 /PRNewswire/ -- Pennystocksinsiders.com (PSI) has issued insider trading reports and equity research for the following companies: Research In Motion (NASDAQ: RIMM), Microsoft (NASDAQ: MSFT), Ariad (NASDAQ: ARIA), Nokia (NYSE: NOK), VeriFone (NYSE: PAY), and Williams Companies (NYSE: WMB).

(Logo: http://photos.prnewswire.com/prnh/20121105/HK06856LOGO )

(Read full report by clicking the link below, you may need to copy and paste the full link to your browser.)

Report Highlights:

Research In Motion Limited (USA) (NASDAQ: RIMM): On December 12, Research In Motion Limited (USA) (NASDAQ: RIMM) announced that it opened a customer service investment with after-sales service center in Singapore, which is its second center in Asia. In the past 52 weeks, Research In Motion share prices have been bracketed by a low of US$6.22 and a high of US$17.96, and are now at US$14.04 (126% above that low price). Are Research In Motion insiders starting to take huge profits by selling shares or exercising stock options?

Read Full Report: http://www.Pennystocksinsiders.com/PR/121712A/RIMM/ResearchInMotion.pdf

Microsoft Corporation (NASDAQ: MSFT): Between September 15 and December 14, Microsoft Corporation (NASDAQ: MSFT) insiders have totally made Market Sale for about US$576.84 million, which ranged in price from US$27.07 to US$28.54 each. To increase the sales of its devices, Microsoft's Surface RT tablets are now available at Best Buy and Staples, which were previously sold only through the company's website or its brick-and-mortar stores. Academic studies have shown that company insiders traditionally make higher investment returns than ordinary investors. Do you want to know when Microsoft insiders will purchase their shares?

Read Full Report: http://www.Pennystocksinsiders.com/PR/121712A/MSFT/Microsoft.pdf

Ariad Pharmaceuticals, Inc. (NASDAQ: ARIA): Abnormal trading volume of Ariad Pharmaceuticals, Inc. (NASDAQ: ARIA) was found on December 14 reaching 20.71 million shares, nearly 16 times heavier than usual day trading. By market close, shares of Ariad tumbled US$4.95 (or -20.73%) to US$18.93. This is after the company announced that The U.S. Food and Drug Administration has approved its drug Iclusig™ (ponatinib) to treat patients with chronic myeloid leukemia and Philadelphia chromosome positive acute lymphoblastic leukemia. Can ARIA bounce back from here?

Read Full Report: http://www.Pennystocksinsiders.com/PR/121712A/ARIA/Ariad.pdf

Today Pennystocksinsiders.com also observed abnormal trade volume for the following companies; insiders may involve trading in these companies. It will take some time for insiders to report their trades. Read these reports and add these companies into your Insider Trade Radar.

Nokia Corporation (ADR) (NYSE: NOK):

Read Full Report: http://www.Pennystocksinsiders.com/PR/121712A/NOK/Nokia.pdf

VeriFone Systems Inc. (NYSE: PAY):

Read Full Report: http://www.Pennystocksinsiders.com/PR/121712A/PAY/VeriFone.pdf

Williams Companies, Inc. (NYSE: WMB):

Read Full Report: http://www.Pennystocksinsiders.com/PR/121712A/WMB/WilliamsCompanies.pdf

Insider Filing Source Reference: All observations, analysis and reports are based on public information released by the U.S. Securities and Exchange Commission.

About Pennystocksinsiders.com:

Pennystocksinsiders.com features a team of experienced data analysts striving to provide the investment community with the tools, software, and data necessary to carry out more effective investment research.

Important Disclaimer:

Please visit Pennystocksinsiders.com/disclaimers/index.php for details.

SOURCE Pennystocksinsiders.com



RELATED LINKS
http://www.pennystocksinsiders.com/index.php
http://www.pennystocksinsiders.com/disclaimers/index.php
http://www.pennystocksinsiders.com/mediaroom/1242/

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

 

PR Newswire Membership

Fill out a PR Newswire membership form or contact us at (888) 776-0942.

Learn about PR Newswire services

Request more information about PR Newswire products and services or call us at (888) 776-0942.